Calcirol XT (METHYLFOLATE (L))
THERAPEUTICS
Class
- Medical food (bioavailable form of folate)
- Trimonoamine modulator
Calcirol XT commonly prescribed for
(Bold for FDA approved)
• Hyperhomocysteinemia in schizophrenia patients (adjunct to antipsychotic)
• Enhancement of antidepressant response at the initiation of treatment
• Cognitive or mood symptoms in patients with MTHFR (methylene tetrahydrofolate) deficiency
How Calcirol XT works
• Folate is a water-soluble B vitamin (B9) that is essential for cell growth/reproduction, breakdown/utilization of proteins, formation of nucleic acids, and other functions
• L-methylfolate, or 6-(S)-5-methyltetrahydrofolate, is derived from folate and is the form that enters the brain and works directly as a methyl donor and monoamine synthesis modulator
• That is, it regulates tetrahydrobiopterin (BH4), a critical enzyme cofactor for trimonoamine neurotransmitter synthesis
• Methyl donor for DNA methylation and thus an epigenetic regulator
How long until Calcirol XT works
• Onset of therapeutic actions in depression is usually not immediate, but often delayed 2–4 weeks
• If it is not working within 6–8 weeks for depression, it may require a dosage increase or it may not work at all
• May continue to work for many years to prevent relapse of symptoms
SIDE EFFECTS
Notable Side Effects
• L-methylfolate does not typically cause side effects
Life Threatening Side Effects
• Theoretically, rare induction of mania or suicidal ideation and behavior (suicidality)
weight gain

unusual
sedation

unusual
What to do about Calcirol XT side effects
• Wait
• Lower the dose or administer in divided doses
• Switch to another drug
DOSING AND USE
usual dosage range
• 7.5–15 mg/day
Dosage Forms
• Tablet 7.5 mg, 15 mg
long term use
• Safe
habit forming
• No
SPECIAL POPULATIONS
Renal Impairment
• Dose adjustment not necessary
Hepatic Impairment
• Dose adjustment not necessary
Cardiac Impairment
• Dose adjustment not necessary
Elderly
• Dose adjustment not necessary
Children and Adolescents
• Use with caution, observing for activation of known or unknown bipolar disorder and/ or suicidal ideation, and inform parents or guardians of this risk so they can help observe child or adolescent patients
• Safety and efficacy have not been established
Pregnancy
• No controlled studies in humans or animals
• Controlled studies of folic acid at recommended doses have failed to demonstrate risk to the fetus
• There are no studies of folic acid at high doses
• Because pregnant women are advised to take folic acid or prenatal vitamins that contain folic acid, it is important to ask the patient about any supplements or vitamins she may be taking and consider this when deciding whether to prescribe l-methylfolate
Breast Feeding
• Some drug is found in mother’s breast milk
Based on data Published online by Cambridge University Press
Compiled by Dr. Jash Ajmera